Close Menu

NEW YORK (GenomeWeb) – SomaLogic and NEC today announced an exclusive deal granting NEC exclusive marketing rights to the Somascan assay in Japan.

NEC will market the assay to biopharmaceutical firms, food companies, and academic research centers in the country. The assay leverages SomaLogic's Somamer technology to identify and quantify 1,129 proteins across a wide range of concentrations in small volumes of various biological samples.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing. 

Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.

Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports. 

In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more.